Behind Leqembi, a new Alzheimer’s treatment


Leqembi, which earned full FDA approval in July, could help improve the lives of patients with early stages of Alzheimer’s. Despite limitations, it offers hope for taking on the challenges of the disease.

USC’s new bonds


As the University moves ahead with bold large-scale projects, its reliance on borrowing from financial markets is growing — drawing concern from a credit ratings agency.

Final verdicts on Trojan Hall, Marks Hall


Countless freshmen have walked the halls, terrorized the communal bathrooms, sweated profusely in rooms with no AC, contracted “mold induced asthma” and, in all that chaos, made friends along the way.

AI’s positive impacts


Amid a flurry of revelations around artificial intelligence and mounting concerns about its ethics, one student organization is working to show that the technology can do some good.